Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Q3 2022 Trading Update

28 Oct 2022 07:00

RNS Number : 4139E
Computacenter PLC
28 October 2022
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

FOR IMMEDIATE RELEASE

Computacenter plc

Q3 Trading Update - 28 October 2022

Computacenter plc ("Computacenter", the "Company" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on unaudited financial information, for the third quarter to 30 September 2022 ("the quarter").

Overview

After two exceptional years Computacenter believes that 2022 will be a year of modest adjusted profit before tax growth. This will be achieved despite the substantial headwind of the unwinding of the Covid-19 cost and utilisation benefits we received in 2020 and 2021. We are benefiting from currency movements and the positive, but limited, contribution from our in-year acquisitions, but these are much smaller than the Covid headwinds.

In the quarter all Segments saw strong performance in Technology Sourcing. The US acquisition we made in July 2022 has performed well. Our Services businesses were more challenged due to the post-Covid-19 effects mentioned above and ongoing cost and inflationary pressures, but some recent contract wins, which have not yet contributed, give us confidence.

The supply chain challenges mean that our inventories remain much higher than last year for the reasons we have explained previously. We expect the supply constraints and the inventory levels to unwind as the year progresses but will not be substantially resolved until well into next year.

Group Outlook

As we look ahead into 2023, we look forward to another year of growth. The Company continues to invest heavily in its future, particularly in its IT roadmap and, understandably, cyber security. These investments, as they increase, will continue to hold back short-term profitability, but we believe they are essential to secure our long-term success. This commitment to invest for the long-term gives us confidence for the future.

We look forward to publishing our Pre-Close Trading Update announcement on Monday 30 January 2023.

Enquiries:

 

Computacenter plc

 

Mike Norris, Chief Executive

+44 (0) 1707 631 601

Tony Conophy, Finance Director

+44 (0) 1707 631 515

Tulchan Communications

 

James Macey White / Matt Low

+44 (0) 2073 534 200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVDLFLLBLEFBL
Date   Source Headline
28th May 20267:00 amRNSAcquisition of Government Acquisitions Inc
19th May 20262:00 pmRNSResult of AGM
8th May 20262:00 pmRNSDirector/PDMR Shareholding
28th Apr 20261:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSQ1 Trading Update – 24 April 2026
8th Apr 202610:00 amRNS2025 Annual Financial Report & Notice of 2026 AGM
27th Mar 202610:00 amRNSDirector/PDMR Shareholding
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results 2025
5th Feb 20261:00 pmRNSBlock Listing Interim Review
22nd Jan 20267:00 amRNSPre-Close Trading Update – 22 January 2026
8th Jan 20267:00 amRNSAcquisition of AgreeYa Solutions Inc
6th Nov 20251:00 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSDirectorate Change
5th Aug 20251:00 pmRNSBlock listing Interim Review
31st Jul 20255:00 pmRNSHolding(s) in Company
31st Jul 20254:30 pmRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSTrading Update – 28 July 2025
26th Jun 20253:00 pmRNSDirector/PDMR Shareholding
15th May 20255:00 pmRNSResult of AGM
13th May 20255:45 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSQ1 Trading Update
9th Apr 20252:30 pmRNS2024 Annual Financial Report & Notice of 2025 AGM
2nd Apr 20252:30 pmRNSDirector/PDMR Shareholding
28th Mar 202510:00 amRNSDirector/PDMR Shareholding
26th Mar 20252:00 pmRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results 2024
6th Feb 202510:00 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNSPre-Close Trading Update
9th Jan 20257:00 amRNSDirectorate Change
16th Dec 20247:00 amRNSDirectorate Change
7th Nov 20245:00 pmRNSDirector/PDMR Shareholding
1st Nov 202412:00 pmRNSTotal Voting Rights
30th Oct 20246:14 pmRNSTransaction in Own Shares
30th Oct 20242:00 pmRNSDirector/PDMR Shareholding
29th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20247:00 amRNSQ3 Trading Update – 28 October 2024
25th Oct 20245:33 pmRNSTransaction in Own Shares
24th Oct 202412:00 pmRNSCancellation of Shares held in Treasury
24th Oct 20249:30 amRNSQ3 Trading Update - Release Date
23rd Oct 20245:49 pmRNSTransaction in Own Shares
22nd Oct 20246:18 pmRNSTransaction in Own Shares
18th Oct 20245:49 pmRNSTransaction in Own Shares
17th Oct 20245:48 pmRNSTransaction in Own Shares
16th Oct 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.